BlackRock Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
BIT
BFA
BlackRock Advisors's DGX Position: Q4 2016 in Review
BlackRock Advisors increased its Quest Diagnostics (DGX) stake by 19% in Q4 2016, buying an estimated $61.3M and bringing the position to 4,408,708 shares worth $405M. The position accounts for 0.41% of the portfolio, ranked #54.
BlackRock Advisors first reported a position in DGX in Q2 2013 and has held it in 15 quarters since. The position peaked at $441M in Q1 2015. 597 funds tracked by Wall St. Rank hold DGX as of Q4 2016.
- BlackRock Advisors held 4,408,708 shares of Quest Diagnostics worth $405M as of Q4 2016.
- BlackRock Advisors bought 710,791 Quest Diagnostics shares in Q4 2016, an estimated $61.3M.
- Quest Diagnostics made up 0.41% of BlackRock Advisors's portfolio in Q4 2016, its #54 holding.
- BlackRock Advisors first reported a position in Quest Diagnostics in Q2 2013 and has held it in 15 quarters since.
- BlackRock Advisors's Quest Diagnostics position peaked at $441M in Q1 2015.
- 597 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2016.
Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.